The estimated Net Worth of Jeanne B. Fisher is at least $12.4 Milion dollars as of 1 February 2010. Jeanne Fisher owns over 41,752 units of Amerisource Bergen stock worth over $12,408,181 and over the last 17 years Jeanne sold ABC stock worth over $0.
Jeanne has made over 3 trades of the Amerisource Bergen stock since 2009, according to the Form 4 filled with the SEC. Most recently Jeanne exercised 41,752 units of ABC stock worth $587,033 on 1 February 2010.
The largest trade Jeanne's ever made was exercising 41,752 units of Amerisource Bergen stock on 1 February 2010 worth over $587,033. On average, Jeanne trades about 12,105 units every 12 days since 2008. As of 1 February 2010 Jeanne still owns at least 68,942 units of Amerisource Bergen stock.
You can see the complete history of Jeanne Fisher stock trades at the bottom of the page.
Jeanne's mailing address filed with the SEC is 1300 MORRIS DRIVE, , CHESTERBROOK, PA, 19087.
Over the last 21 years, insiders at Amerisource Bergen have traded over $4,389,593,610 worth of Amerisource Bergen stock and bought 18,610 units worth $1,659,872 . The most active insiders traders include Boots Alliance, Inc.Walgree..., Lon R Greenberg oraz Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of $13,111,903. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth $813,987.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: